Angie Lay-Keng Tan

A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets

Niantao Deng, Liang Kee Goh, Hannah Wang et al. · Gut · 2012 · 635 citations · Full text

Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial

Raghav Sundar, Nesaretnam Barr Kumarakulasinghe, Yiong Huak Chan et al. · Gut · 2021 · 56 citations · Full text

Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent <i>CCNE1</i> and <i>IGF2</i> enhancer hijacking in primary gastric adenocarcinoma

Wen Fong Ooi, Amrita M. Nargund, Kevin Lim et al. · Gut · 2019 · 50 citations

Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition

Raghav Sundar, Kie Kyon Huang, Vikrant Kumar et al. · Gut · 2021 · 39 citations · Full text

Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer.

Hue-Kian Oh, Angie Lay-Keng Tan, Kakoli Das et al. · 2011 · 20 citations

Tumor Biology, Gastrointestinal Oncology, Medicine +12